-
BioGeneration Ventures co-leads €25 million Series A fundraising in NorthSea Therapeutics and its promising NASH drug programma
December 14, 2017BGV co-leads €25 million Series A fundraising in NorthSea Therapeutics and its promising NASH drug programme Lead drug icosabutate,...
0 -
BioGeneration Ventures Fund III reaches EUR 82 million in final close
October 31, 2017BioGeneration Ventures Fund III reaches EUR 82 million in final close Investments from Bristol-Myers Squibb and Johnson & Johnson...
